A Study To Determine Bioequivalence Between The Commercial Femulen Tablets And A Reformulation Of Femulen Tablets In Healthy Female Subjects
NCT01359163
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Therapeutic Equivalency
Interventions
DRUG:
etynodiol diacetate
DRUG:
etynodiol diacetate
Sponsor
Pfizer